You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cystic fibrosis

Mannitol dry powder for inhalation for treating cystic fibrosis

  • Technology appraisal guidance
  • Reference number: TA266
  • Published:  28 November 2012
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Cystic fibrosis - mannitol: Pharmaxis

Cystic fibrosis - mannitol: Pharmaxis Cystic fibrosis - mannitol: Pharmaxis
26 October 2012
(3 Mb 54 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 24 October 2012

Back to top